Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations

Trial Identifier:	D8455L00002
Sponsor:	AstraZeneca
Start Date:	April 2026
Primary Completion Date:	November 2027
Study Completion Date:	November 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	fuzhou, CN, 350005
CN	Jinan, CN, 250012
CN	Shanghai, CN, 200032

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.